Contrasting ASP Isotopes (ASPI) and Its Competitors

ASP Isotopes (NASDAQ:ASPIGet Free Report) is one of 18 publicly-traded companies in the “Miscellaneous chemical products” industry, but how does it contrast to its peers? We will compare ASP Isotopes to related businesses based on the strength of its profitability, institutional ownership, valuation, analyst recommendations, risk, dividends and earnings.

Institutional & Insider Ownership

1.5% of ASP Isotopes shares are held by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are held by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares ASP Isotopes and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ASP Isotopes N/A -$4.95 million -3.11
ASP Isotopes Competitors $1.26 billion $32.20 million 11.27

ASP Isotopes’ peers have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for ASP Isotopes and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ASP Isotopes 0 0 0 0 N/A
ASP Isotopes Competitors 31 329 310 6 2.43

As a group, “Miscellaneous chemical products” companies have a potential upside of 14.98%. Given ASP Isotopes’ peers higher probable upside, analysts clearly believe ASP Isotopes has less favorable growth aspects than its peers.


This table compares ASP Isotopes and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ASP Isotopes N/A -116.87% -90.49%
ASP Isotopes Competitors -21.17% 0.85% -7.44%


ASP Isotopes peers beat ASP Isotopes on 8 of the 9 factors compared.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with's FREE daily email newsletter.